Central Trust Company’s Axcelis ACLS Stock Holding History

Central Trust Company’s Portfolio ACLS Stock Details ACLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$77.5K	Sell	409 -828	-67%	-$123K	﹤0.01%	788
2026 Q1	$115K	Sell	1,237 -113	-8%	-$10K	﹤0.01%	693
2025 Q4	$108K	Hold	1,350	–	–	﹤0.01%	681
2025 Q3	$132K	Hold	1,350	–	–	﹤0.01%	647
2025 Q2	$94.1K	Buy	1,350 +1,237	+1,095%	+$70.6K	﹤0.01%	682
2025 Q1	$5.61K	Hold	113	–	–	﹤0.01%	1194
2024 Q4	$7.9K	Hold	113	–	–	﹤0.01%	1144
2024 Q3	$11.8K	Hold	113	–	–	﹤0.01%	1041
2024 Q2	$16.1K	Hold	113	–	–	﹤0.01%	980
2024 Q1	$12.6K	Hold	113	–	–	﹤0.01%	1041
2023 Q4	$14.7K	Hold	113	–	–	﹤0.01%	1007
2023 Q3	$18.4K	Hold	113	–	–	﹤0.01%	946
2023 Q2	$20.7K	Hold	113	–	–	﹤0.01%	926
2023 Q1	$15.1K	Buy	+113	New	+$13.3K	﹤0.01%	985

Other funds holding ACLS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Central Trust Company's ACLS Position: Q2 2026 in Review

Central Trust Company reduced its Axcelis (ACLS) stake by 67% in Q2 2026, selling an estimated $123K and leaving 409 shares worth $77.5K. The position accounts for ﹤0.01% of the portfolio, ranked #788.

Central Trust Company first reported a position in ACLS in Q1 2023 and has held it in 14 quarters since. The position peaked at $132K in Q3 2025. 441 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

Central Trust Company held 409 shares of Axcelis worth $77.5K as of Q2 2026.
Central Trust Company sold 828 Axcelis shares in Q2 2026, an estimated $123K.
Axcelis made up ﹤0.01% of Central Trust Company's portfolio in Q2 2026, its #788 holding.
Central Trust Company first reported a position in Axcelis in Q1 2023 and has held it in 14 quarters since.
Central Trust Company's Axcelis position peaked at $132K in Q3 2025.
441 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Central Trust Company's 13F filing for Q2 2026, filed 31 Jul 2026.